Real-time funding, M&A, exec moves & hiring — the signals that move deals
More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.
Loading live signals…
Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.
Agenus Inc. raises $85 million in a private placement led by Commodore Capital to advance its ROBBIN trial for colon cancer, with potential total proceeds of $340 million.
PUBLIC · AGENJul 13, 2026•15 days ago
Amount Raised
$85 Million
Round Type
Post-IPO Equity
LexingtonBiotechnologyInvestors
InvusTcgxRa Capital ManagementCommodore Capital
Description
Agenus Inc. has announced a private placement to raise approximately $85 million in upfront gross proceeds, with a potential total of up to $340 million. The financing will support the company's ROBBIN trial for neoadjuvant BOT+BAL in MSS colon cancer. The round was led by Commodore Capital and included notable participants
Related People
Suggested for you
2 contactsFunding Insights
Based on industry dataVC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech
Watching Agenus? See every signal — funding, hires, M&A, contracts, sentiment.
Book a demoChoose your plan